Skip to main content
Taltz

Thank you for your interest in the Zepbound® (tirzepatide) Savings for Taltz Patients Program!

Please see Indications and Safety Summary with Warnings for Zepbound.

Every situation is unique and there may be nuances that affect your ability to enroll. Because of this, we have built a tool to help you understand if you may be eligible for the program.
Please answer the following questions so that we can point you in the right direction.

1: Do you have prescriptions for an approved use consistent with FDA-approved product labeling for both Taltz and Zepbound?

Talk with your doctor.

2: Please select the option that best matches your insurance situation

Unfortunately, you are not eligible for this program at this time. If you are interested in other ways to save on Zepbound, please call 1-800-LillyRx. When prompted with selections for “Information on Lilly products,” select 1 for Consumer, then select 1 for Zepbound.

Acknowledge and Exit

3: Have you enrolled in the Taltz Savings Card program?

If you have coverage for Taltz and continue to meet the eligibility requirements for the Taltz Savings Card (review eligibility requirements and terms and conditions here), you may need to reauthorize your HIPAA consent if you live in ME, MD, MT, or have a military address. To reauthorize your HIPAA consent, please call 1-800-LillyRx.

The "pay as little $25" savings card is for patients who do not have coverage for Taltz. Unfortunately, if you do not have coverage for Taltz, you are not eligible for the Zepbound Savings for Taltz Patients Savings Card at this time.

If your insurance does cover Taltz or if it begins to cover Taltz in the future, you may become eligible for the Zepbound Savings for Taltz Patients Savings Card at that time.

If you are interested in other ways to save on Zepbound, please call 1-800-LillyRx. When prompted with selections for "Information on Lilly products," select 1 for Consumer, then select 1 for Zepbound.

Acknowledge and Exit

Does your insurance cover Taltz AND do you otherwise meet the eligibility requirements for the Taltz Savings Card? Review eligibility requirements and terms and conditions here.

If the answer to both of those questions is yes, then you are likely eligible for the Zepbound Savings for Taltz Patients Savings Card. You will need to enroll in the program here.

Note: After enrolling in the Zepbound Savings for Taltz Patients Savings Card Program, please call 1-833-366-7157 before filling your Zepbound prescription to ensure the savings for Zepbound are properly applied.

If the answer to either of the above questions is no, you are not eligible for the Zepbound Savings for Taltz Patients Savings Card Program.

Does your insurance cover Taltz AND do you otherwise meet the eligibility requirements for the Taltz Savings Card? Review eligibility requirements and terms and conditions here.

If the answer to both of those questions is yes, then you must enroll in the Taltz Savings Card Program before enrolling in the Zepbound Savings for Taltz Patients Savings Card. You can enroll in both here.

If the answer to either of the above questions is no, you are not eligible for the Zepbound Savings for Taltz Patients Savings Card Program.

4: Have you filled your Taltz prescription within the past 45 days?

Have you filled a two-month supply of Taltz within the past 90 days or have you filled a three-month supply of Taltz within the past 110 days?

If you have a Taltz prescription that you intend to fill, you may enroll in the Zepbound Savings for Taltz Patients program here. After enrolling, you will be able to fill your first month of Zepbound for $25 but you must fill your Taltz within 45 days (for a one month supply*) of your subsequent Zepbound fills to continue saving on Zepbound.

*If you are filling a two-month supply of Taltz, you must fill within 90 days of filling Zepbound. If you are filling a three-month supply of Taltz, you must fill within 110 days of filling Zepbound.

If you have a Taltz prescription that you intend to fill, you may enroll in the Zepbound Savings for Taltz Patients program here. After enrolling, you will be able to fill your first month of Zepbound for $25 but you must fill your Taltz within 45 days (for a one month supply*) of your subsequent Zepbound fills to continue saving on Zepbound.

*If you are filling a two-month supply of Taltz, you must fill within 90 days of filling Zepbound. If you are filling a three-month supply of Taltz, you must fill within 110 days of filling Zepbound.

If this is your first time filling your Taltz prescription, be sure to wait 3 days before you attempt to fill your Zepbound prescription.

5: Have you downloaded a Zepbound Savings for Taltz Patients Savings Card?

Based on your responses to these questions, you’re likely eligible for the Zepbound Savings for Taltz Patients Savings Card if you continue to meet all the eligibility requirements. Please review the Terms and Conditions here. Governmental beneficiaries excluded, terms and conditions apply. If you need savings card details for your Zepbound Savings for Taltz Patients Card, click here. If you are asked to pay more for Zepbound than you expected, please call 1-833-366-7157 for more information.

Acknowledge and Exit

You may be eligible for the Zepbound Savings for Taltz Patients Savings Card if you meet all the eligibility requirements and download the Zepbound Savings for Taltz Patients Savings Card. Please review the Terms and Conditions here. Governmental beneficiaries excluded, terms and conditions apply. To utilize this savings card, you will first need to enroll in the program here if eligible and download your savings card. If you run into any issues when you attempt to fill your Zepbound prescription, you may need to provide some additional information to receive the savings. Please call 1-833-366-7157 for more information.

Acknowledge and Exit

If it has not been more than 1 business day since you downloaded your Taltz Savings Card, please wait 1 business day before you attempt to enroll in Zepbound Savings for Taltz Patients Savings Card. If this does not resolve your issue or does not apply to you, please call 1-800-LillyRx. When prompted with selections for “Information on Lilly products,” select 1 for Consumer, then select 3 for Taltz.

Acknowledge and Exit

Step of 5

SAFETY SUMMARY

Warnings - Taltz affects the immune system. It may increase your risk of infections, some people have had serious infections, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have been hospitalized from these infections. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.

Your doctor should check you for TB before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz. If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.

Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.

Severe skin reactions that look like eczema can happen during treatment with Taltz from days to months after your first dose and can sometimes lead to hospitalization. Your doctor may temporarily stop treatment with Taltz if you develop severe skin reactions. Tell your doctor if you have any of the following: redness or rash, itching, patches, your skin is dry or feels like leather, blisters or abrasions that ooze or become crusty, small bumps or plaques with scale or crusting.

Crohn’s disease or ulcerative colitis (inflammatory bowel disease) can start or get worse with Taltz use. Tell your doctor if you have any of these symptoms or if they get worse: stomach pain, diarrhea, and weight loss.

You should not get live vaccines while taking Taltz. You should get the vaccines you need before you start Taltz.

Common side effects
The most common side effects of Taltz include:

  • Injection site reactions

  • Nausea

  • Upper respiratory infections

  • Fungal skin infections

Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using

Before you use Taltz, review these questions with your doctor:

❑ Are you being treated for an infection?
❑ Do you have an infection that does not go away or keeps coming back?
❑ Do you have TB or have you been in close contact with someone with TB?
❑ Do you have possible symptoms of an infection such as fever, cough, sores, diarrhea, or other symptoms? Ask your doctor about other possible symptoms.
❑ Do you have Crohn’s disease or ulcerative colitis?

Tell your doctor if:

❑ You need any vaccines or have had one recently.
❑ You take prescription or over-the-counter medicines, vitamins, or herbal supplements.
❑ You are pregnant or planning to become pregnant. It is not known if Taltz can harm an unborn baby. Pregnancy Exposure Registry: There is a pregnancy registry to collect information about women who are exposed to Taltz during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. If you become pregnant while taking Taltz, you are encouraged to enroll in the pregnancy registry by calling 1-800-284-1695 or by visiting online at http://www.pregnancyregistry.lilly.com.
❑ You are breastfeeding or planning to breastfeed. It is not known if Taltz passes into breastmilk.

How to take

See the instructions for use that come with Taltz. There you will find information about how to store, prepare, and inject Taltz. Adults may self-inject after receiving training from a healthcare provider.

For children 6 to 17 years of age:

  • If your child’s healthcare provider decides that you may give Taltz injections at home, you should receive training on the right way to prepare and inject Taltz. Do not try to give Taltz to your child until you have been shown how to inject Taltz. Children should not inject themselves with Taltz. You or an adult caregiver should prepare and give Taltz injections to your child.

Learn more

Taltz is a prescription medicine available as a 80 mg/mL, 40 mg/0.5mL, 20 mg/0.25mL injection. For more information, call 1-800-545-5979 or go to taltz.lilly.com.

This summary provides basic information about Taltz but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Taltz and how to take it. Your doctor is the best person to help you decide if Taltz is right for you.

IX CON BS 20AUG2024

Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
INDICATIONS

SAFETY SUMMARY

Warnings - Taltz affects the immune system. It may increase your risk of infections, some people have had serious infections, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have been hospitalized from these infections. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.

Your doctor should check you for TB before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz. If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.

Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.

Severe skin reactions that look like eczema can happen during treatment with Taltz from days to months after your first dose and can sometimes lead to hospitalization. Your doctor may temporarily stop treatment with Taltz if you develop severe skin reactions. Tell your doctor if you have any of the following: redness or rash, itching, patches, your skin is dry or feels like leather, blisters or abrasions that ooze or become crusty, small bumps or plaques with scale or crusting.

Crohn’s disease or ulcerative colitis (inflammatory bowel disease) can start or get worse with Taltz use. Tell your doctor if you have any of these symptoms or if they get worse: stomach pain, diarrhea, and weight loss.

You should not get live vaccines while taking Taltz. You should get the vaccines you need before you start Taltz.

Common side effects
The most common side effects of Taltz include:

  • Injection site reactions

  • Nausea

  • Upper respiratory infections

  • Fungal skin infections

Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before using

Before you use Taltz, review these questions with your doctor:

❑ Are you being treated for an infection?
❑ Do you have an infection that does not go away or keeps coming back?
❑ Do you have TB or have you been in close contact with someone with TB?
❑ Do you have possible symptoms of an infection such as fever, cough, sores, diarrhea, or other symptoms? Ask your doctor about other possible symptoms.
❑ Do you have Crohn’s disease or ulcerative colitis?

Tell your doctor if:

❑ You need any vaccines or have had one recently.
❑ You take prescription or over-the-counter medicines, vitamins, or herbal supplements.
❑ You are pregnant or planning to become pregnant. It is not known if Taltz can harm an unborn baby. Pregnancy Exposure Registry: There is a pregnancy registry to collect information about women who are exposed to Taltz during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. If you become pregnant while taking Taltz, you are encouraged to enroll in the pregnancy registry by calling 1-800-284-1695 or by visiting online at http://www.pregnancyregistry.lilly.com.
❑ You are breastfeeding or planning to breastfeed. It is not known if Taltz passes into breastmilk.

How to take

See the instructions for use that come with Taltz. There you will find information about how to store, prepare, and inject Taltz. Adults may self-inject after receiving training from a healthcare provider.

For children 6 to 17 years of age:

  • If your child’s healthcare provider decides that you may give Taltz injections at home, you should receive training on the right way to prepare and inject Taltz. Do not try to give Taltz to your child until you have been shown how to inject Taltz. Children should not inject themselves with Taltz. You or an adult caregiver should prepare and give Taltz injections to your child.

Learn more

Taltz is a prescription medicine available as a 80 mg/mL, 40 mg/0.5mL, 20 mg/0.25mL injection. For more information, call 1-800-545-5979 or go to taltz.lilly.com.

This summary provides basic information about Taltz but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Taltz and how to take it. Your doctor is the best person to help you decide if Taltz is right for you.

IX CON BS 20AUG2024

Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

INDICATIONS

Taltz® (tȯl-ts) is an injectable medicine used to treat:

  • People 6 years of age and older with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

  • Adults with active psoriatic arthritis.

  • Adults with active ankylosing spondylitis.

  • Adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

It is not known if Taltz is safe and effective in children for conditions other than plaque psoriasis or in children under 6 years of age.